CACI: The Stock Is Off Its High, but the Cash Flow Isn't

The market is still pricing CACI International like a defense contractor worried about federal budgets and sequester headlines. The stock sits at $518 - down roughly 24% from its 52-week high of $683 and flat year-to-date. The old story is budget risk. The cash flow says something different.

CACI just closed fiscal 2026 and the numbers are the kind of operating improvement that doesn't happen to a business stuck in the narrative the tape is still telling. Revenue reached $9.6 billion, up 10.9% year over year. Adjusted diluted EPS - net income after stripping one-time items - came in at $29.83, up 12.7%. EBITDA margin expanded to 12.3%. But the proof point I care about is free cash flow: $735.4 million, a 66% jump from the prior year.

Sixty-six percent is not a rounding error. That is an operating inflection. It means CACI is converting a growing revenue base into cash faster than it was before, which is the exact kind of acceleration that sets up a rerating once the broader market stops discounting the name.

The 12-month bridge

Management guided fiscal 2027 adjusted EPS to a midpoint of $33.41 (range $32.96 to $33.86), well above the analyst consensus of roughly $30.70 at the time of the report - an 8.4% upside surprise built into the outlook. Revenue guidance sits at $10.65 billion to $10.85 billion at the midpoint, also ahead of the $10.66 billion estimate.

More importantly, CACI is guiding for at least $900 million in fiscal 2027 free cash flow. That guidance assumes roughly $115 million in cash tax benefits, so the underlying operating cash generation is somewhat lower than the headline figure. Even net of that, the implied free cash flow trajectory represents another roughly 23% jump from this year's $735.4 million. That is not a whiff - it is a credible path to a materially larger cash pile.

The backlog - the pool of contracted work not yet delivered - stands at $32 billion, up 3.2% year over year. Full-year book-to-bill (the ratio of new contract awards to revenue recognized) was 1.1x, meaning CACI brought in more work than it delivered. The backlog growth rate has trailed revenue growth, which raises the standard question about pipeline sustainability. But the company also told investors it is on track to meet or exceed its own three-year financial targets, which are explicitly anchored to free cash flow growth, not just top-line revenue.

Why the tape disagrees

CACI has been down 9.6% over the past 120 days and below its 200-day moving average. The stock opened today at $525 and closed yesterday at $524, bouncing around $518. For a business that grew free cash flow by 66% and is guiding for $900 million, this tape looks like sentiment lag, not business deterioration.

The disconnect is classic. The headlines are still about federal budget uncertainty, the noise around the ARKA acquisition's added interest expense, and the broader defense sector's cyclical anxiety. None of that has stopped the operating machine. Q4 revenue grew 17.6% year over year, with 11.6% of that coming from organic growth. Operating income jumped 31.7%. Adjusted EPS beat by 23.2% versus the $7.23 estimate. Free cash flow for the quarter alone was $232.9 million, up 67.4% year over year.

AInvest's aggregate signal labels CACI a Buy, with a fundamental rating of 7.88 out of 10. The opaque scoring doesn't replace the proof path, but it does show that the broader analyst consensus hasn't been dragged down to the same level of pessimism the tape reflects. That gap - between the consensus and the tape - is where the entry usually sets up.

The financial bridge to a target

This is not a DCF exercise. Simple forward multiples beat complex models when the cash flow path is credible. Here's the bridge:

If CACI delivers its midpoint FY2027 adjusted EPS of $33.41, and the stock earns a forward multiple of 16x - roughly in line with its historical trading range and not out of reach for a name growing adjusted EPS at 12% with expanding margins - the implied price is approximately $535. That is a floor scenario where nothing changes but guidance executes.

The more interesting path runs through free cash flow. At $900 million in guided FCF, even a conservative 8.5x FCF multiple implies an enterprise value of $7.65 billion. Add back net cash and the implied equity value pushes toward $545 per share. At 9x, you're at roughly $560.

I'll put a number on it. A $560 target, 12 months out, if the company delivers its guided free cash flow and EPS. That is roughly 8% upside from today's $518 - not a home-run number, but a measured inflection setup where the downside is narrower than the tape suggests and the operating trajectory is positive.

What would break it

The thesis is simple enough to invalidate. If FY2027 free cash flow falls meaningfully short of the $900 million guidance - say, below $750 million after accounting for the $115 million in assumed tax benefits - the rerating case weakens. If backlog growth stalls and book-to-bill drops below 1x, the pipeline concern becomes a real one. And if defense budget cuts hit CACI's core intelligence and homeland security contracts harder than the current outlook assumes, the whole operating bridge collapses.

A tripwire below $440 - roughly at the stock's 52-week low - would signal that the market has decided the budget risk is more material than the cash flow story. Discipline over ego. Cut if that level breaks and you can't justify the gap.

But for now, the operating setup is getting cleaner while the market is still pricing the old story. That is the inflection. The question is whether you're willing to buy it before consensus feels comfortable.